A message from General Atomics

Advanced Nuclear Fuel Cladding: Innovative Materials Enhance Fleet Safety and Performance

Protein shows potential to accelerate cancer therapy research and application

October 25, 2021, 3:05PMNuclear News

LLNL and Penn State researchers developed a new approach to study and purify medical isotopes, including actinium. (Image: Thomas Reason/LLNL)

Scientists at Lawrence Livermore National Laboratory and Pennsylvania State University have demonstrated that a natural protein found bonded to rare earth elements can be recovered and used as a tool to purify and effectively manage radioactive metals that show promise for cancer therapy and the detection of illicit nuclear activities.

To continue reading, log in or create a free account!

BWXT to acquire Kinectrics in “complementary” $525M deal

January 8, 2025, 12:01PMNuclear News

Nuclear manufacturer BWX Technologies has announced its plan to acquire Kinectrics Inc. for approximately $525 million. The deal is expected to close in mid-2025....

What’s different about Pacific Fusion’s pulsed magnetic concept?

October 30, 2024, 7:00AMNuclear News

With more than 40 fusion development companies announcing plans and funding, it’s hard for a newcomer to stand out, but Pacific Fusion is giving it a try. The company, based in Fremont,...

N. Prasad Kadambi—ANS member since 1972

August 27, 2024, 3:29PMNuclear News

We welcome ANS members who have careered in the community to submit their own Nuclear Legacy stories, so that the personal history of nuclear science and technology can be captured. For...

General Atomics R&D team recognized for contributions to NIF’s fusion ignition

August 13, 2024, 9:43AMNuclear News

The National Ignition Facility (NIF) at Lawrence Livermore National Laboratory has achieved fusion ignition at least five times, each time by directing its 192 high-powered lasers on a capsule...

Missouri radioisotope producer MURR joins European nuclear medicine group

July 22, 2024, 9:30AMNuclear News

The University of Missouri Research Reactor (MURR) is the latest member of Nuclear Medicine Europe, an industry association for the radiopharmaceutical and molecular imaging industry in...

Why is ITER valuable for the U.S.?

July 2, 2024, 9:36AMNuclear NewsLynne Degitz

Public and private sectors are actively advancing research and development and concepts to realize a path to practical, clean, safe fusion energy. New fusion performance records continue to be...

Decay on Demand: DARPA’s bid to disrupt isotope production

July 2, 2024, 7:00AMNuclear News

The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) wants to mimic and accelerate the natural half-life decay chain of alpha-emitting radioisotopes and plans to...

Strontium: Supply-and-demand success for the DOE’s Isotope Program

May 2, 2024, 3:15PMNuclear News

The Department of Energy’s Isotope Program (DOE IP) announced last week that it would end its “active standby” capability for strontium-82 production about two decades after beginning...

Penn State welcomes neutron scattering device—a first of a kind in the U.S.

March 19, 2024, 9:37AMNuclear News

Staff and researchers at Penn State’s Radiation Science and Engineering Center (RSEC) will work this year to install a small angle neutron scattering (SANS) device and become the first and...

Taking aim at disease

Radioisotopes target cancer, improve imaging, and have myriad other medical uses

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...

Protein shows potential to accelerate cancer therapy research and application

Related Articles